It is estimated that by 2025, the market scale and CAGR forecast of China’s diagnostic antibody raw material industry will be 8.19 billion yuan and 18.8% respectively
The main application platforms of antibody raw materials for diagnosis include radioimmunoassay, enzyme-linked immunosorbent assay, chemiluminescence immunoassay and immunoturbidimetry. The principles of diagnostic antibody raw materials for detection mainly include double antibody sandwich method, competition method, indirect method and capture method. In 2020, the market scale of China’s diagnostic antibody raw material industry is RMB 3.46 billion, and the CAGR from 2016 to 2020 is 25.3%. It is estimated that the market scale of China’s diagnostic antibody raw material industry is RMB 8.09 billion by 2025, and the CAGR from 2020 to 2025 is 18.5%
As the upstream of the industrial chain, the sales of diagnostic antibody raw materials are mainly affected by the demand for in vitro diagnostic reagents in the midstream
As the upstream of the industrial chain, antibody raw materials for diagnosis are sold to the midstream in vitro diagnostic reagent manufacturers, and finally the midstream in vitro diagnostic reagent manufacturers meet the downstream demand market. Upstream enterprises are dominated by Sino Biological Inc(301047) , Kingsley and Feipeng biological diagnostic antibody raw materials. From 2016 to 2020, the CAGR of IVD market scale in the midstream 1 ^# is 23.4%, while the CAGR of clinical testing market scale in downstream China and ICL market scale in China (excluding covid-19 testing) are 11.5% and 14.1% respectively
Imported products still dominate the market of in vitro diagnostic reagent raw materials, and Chinese diagnostic antibody raw materials enterprises are distributed in many provinces
In 2020, the sales of imported and domestic IVD raw materials in China were 8.9 billion yuan and 1.2 billion yuan respectively. Imported products still occupy the leading position in the raw material market of in vitro diagnostic reagents. Chinese diagnostic antibody raw materials enterprises are distributed in many provinces, including Beijing, Shanghai, Jiangsu and Guangdong. In addition, from a global perspective, the IVD raw material market is characterized by a large number of participants, small individual scale and highly dispersed industry
